Literature DB >> 7587430

Acute lung disease in the immunocompromised host. Diagnostic accuracy of the chest radiograph.

P M Logan1, S L Primack, C Staples, R R Miller, N L Müller.   

Abstract

PURPOSE: To assess the diagnostic accuracy of the chest radiograph in the evaluation of acute pulmonary complications in immunocompromised patients.
METHODS: The study included the chest radiographs in 149 consecutive acute pulmonary complications seen in immunocompromised patients in whom a definitive diagnosis was made. Twenty-four complications were in patients with AIDS and 125 were in non-AIDS patients. The radiographs were separately reviewed in random order by two independent observers. The observers assessed pattern and distribution of radiographic findings and recorded their first-choice diagnosis.
RESULTS: The most common complication in patients with AIDS was Pneumocystis carinii pneumonia (n = 21). In the non-AIDS patients, the most common complications included invasive aspergillosis (n = 25), drug reaction (n = 21), and Pneumocystis pneumonia (n = 20). A correct first-choice diagnosis was made in 90% of patients with AIDS and 34% of non-AIDS patients. IN AIDS patients with Pneumocystis pneumonia, the correct first-choice diagnosis was made in 41 of 42 (98%) readings by the two observers. In non-AIDS patients with invasive pulmonary aspergillosis, drug reaction, and Pneumocystis pneumonia, the correct first-choice diagnosis was made in 38%, 26%, and 43% of readings, respectively.
CONCLUSION: The chest radiograph is helpful in the differential diagnosis of acute lung disease in the immunocompromised host, particularly in patients with AIDS.

Entities:  

Mesh:

Year:  1995        PMID: 7587430     DOI: 10.1378/chest.108.5.1283

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  11 in total

Review 1.  A persistent challenge: the diagnosis of respiratory disease in the non-AIDS immunocompromised host.

Authors:  C Mayaud; J Cadranel
Journal:  Thorax       Date:  2000-06       Impact factor: 9.139

Review 2.  Pulmonary infiltrates in the immunocompromised: diagnosis and management.

Authors:  D Peckham; M W Elliott
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

Review 3.  [Pneumonias and immunosuppression].

Authors:  K Dalhoff; J Marxsen; J Steinhoff
Journal:  Internist (Berl)       Date:  2007-05       Impact factor: 0.743

4.  Impact of clinical data on chest radiography sensitivity in detecting pulmonary abnormalities in immunocompromised patients with suspected pneumonia.

Authors:  L Cereser; C Zuiani; G Graziani; R Girometti; G Como; F Zaja; M Bazzocchi
Journal:  Radiol Med       Date:  2009-08-07       Impact factor: 3.469

Review 5.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

Review 6.  High-resolution computed tomography (HRCT) of lung infections in non-AIDS immunocompromised patients.

Authors:  Tomás Franquet
Journal:  Eur Radiol       Date:  2005-10-14       Impact factor: 5.315

Review 7.  Viral Pneumonia in Patients with Hematologic Malignancy or Hematopoietic Stem Cell Transplantation.

Authors:  Erik Vakil; Scott E Evans
Journal:  Clin Chest Med       Date:  2016-12-16       Impact factor: 2.878

Review 8.  Drug-Induced Interstitial Lung Disease: A Systematic Review.

Authors:  Sarah Skeoch; Nicholas Weatherley; Andrew J Swift; Alexander Oldroyd; Christopher Johns; Conal Hayton; Alessandro Giollo; James M Wild; John C Waterton; Maya Buch; Kim Linton; Ian N Bruce; Colm Leonard; Stephen Bianchi; Nazia Chaudhuri
Journal:  J Clin Med       Date:  2018-10-15       Impact factor: 4.241

Review 9.  Pneumonia in hospitalized children.

Authors:  Thomas J Sandora; Marvin B Harper
Journal:  Pediatr Clin North Am       Date:  2005-08       Impact factor: 3.278

10.  Comparison of initial high resolution computed tomography features in viral pneumonia between metapneumovirus infection and severe acute respiratory syndrome.

Authors:  Cheuk Kei Kathy Wong; Vincent Lai; Yiu Chung Wong
Journal:  Eur J Radiol       Date:  2011-03-25       Impact factor: 3.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.